Nephros Inc (NEPH): Next-Year EPS Estimate 122.22%
As of 2026-06-11, Nephros Inc (NEPH) has a next-year EPS growth estimate of 122.22%.
On 2026-05-11, analyst consensus for NEPH's next-year EPS growth shifted from 117.63% to 122.22% — a positive change of 4.59 percentage points. The revised estimate has been sustained across 24 subsequent trading sessions. Current-year growth is projected at -59.09%.
Current Snapshot
- Sector
- Healthcare
- Industry
- Medical Instruments & Supplies
- EPS growth next year
- 122.22%
- EPS growth this year
- -59.09%
- EPS next quarter (est)
- $0.00
- Last price
- $3.33
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-06-11 | 122.22% | -59.09% | $0.00 | $3.33 |
| 2026-06-10 | 122.22% | -59.09% | $0.00 | $3.20 |
| 2026-06-09 | 122.22% | -59.09% | $0.00 | $3.25 |
| 2026-06-08 | 122.22% | -59.09% | $0.00 | $3.39 |
| 2026-06-07 | 122.22% | -59.09% | $0.00 | $3.42 |
| 2026-06-04 | 122.22% | -59.09% | $0.00 | $3.59 |
| 2026-06-03 | 122.22% | -59.09% | $0.00 | $3.64 |
| 2026-06-02 | 122.22% | -59.09% | $0.00 | $3.80 |
| 2026-06-01 | 122.22% | -59.09% | $0.00 | $3.69 |
| 2026-05-31 | 122.22% | -59.09% | $0.00 | $3.66 |
| 2026-05-28 | 122.22% | -59.09% | $0.00 | $3.70 |
| 2026-05-27 | 122.22% | -59.09% | $0.00 | $3.60 |
| 2026-05-26 | 122.22% | -59.09% | $0.00 | $3.58 |
| 2026-05-25 | 122.22% | -59.09% | $0.00 | $3.47 |
| 2026-05-24 | 122.22% | -59.09% | $0.00 | $3.47 |
| 2026-05-21 | 122.22% | -59.09% | $0.00 | $3.69 |
| 2026-05-20 | 122.22% | -59.09% | $0.00 | $3.57 |
| 2026-05-19 | 122.22% | -59.09% | $0.00 | $3.63 |
| 2026-05-18 | 122.22% | -59.09% | $0.00 | $3.68 |
| 2026-05-17 | 122.22% | -59.09% | -$0.01 | $3.13 |
| 2026-05-14 | 122.22% | -59.09% | -$0.01 | $3.34 |
| 2026-05-13 | 122.22% | -59.09% | -$0.01 | $3.42 |
| 2026-05-12 | 122.22% | -59.09% | -$0.01 | $3.01 |
| 2026-05-11 | 122.22% | -59.09% | -$0.01 | $2.95 |
| 2026-05-10 | 117.63% | -58.23% | -$0.01 | $3.52 |
| 2026-05-07 | 116.67% | -45.45% | $0.01 | $3.23 |
| 2026-05-06 | 116.67% | -45.45% | $0.01 | $3.22 |
| 2026-05-05 | 116.67% | -45.45% | $0.01 | $3.14 |
| 2026-05-04 | 116.67% | -45.45% | $0.01 | $3.07 |
| 2026-05-03 | 116.67% | -45.45% | $0.01 | $3.11 |
Screen Performance
Aggregate stats across all 1781 tickers our top-EPS-revision screen has flagged over the past 71 days.
- Median return since detection
- +3.8%
- % of tickers in the green
- 58%
- Median return on winners
- +18.5%
- Large revisions captured
- 788
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Frequently Asked Questions
What is Nephros Inc's next-year EPS growth estimate?▾
As of 2026-06-11, Nephros Inc (NEPH) has a next-year EPS growth estimate of 122.22%, based on analyst consensus.
When was the latest EPS estimate revision for NEPH?▾
The most recent revision occurred on 2026-05-11, when analysts adjusted the next-year EPS growth estimate from 117.63% to 122.22%.
What sector and industry does Nephros Inc belong to?▾
Nephros Inc operates in the Healthcare sector, specifically the Medical Instruments & Supplies industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. NEPH appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. Nephros Inc (NEPH) appears here because it was detected by our daily top-EPS-revision-performer screen.
← All reports